Keeping up with the newborn screening revolution

Contemporary Pediatrics

Volumn 24, Issue 4, 2007, Pages

  Tarini, Beth A ^a,b   Freed, Gary L ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34249689535     PISSN: 87500507     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Guthrie R: Blood screening for phenylketonuria. JAMA 1961;178:863
2. National Research Council, Committee for the Study of Inborn Errors of Metabolism: Genetic Screening: Programs, principles and research. Washington, D.C.: National Academy of Sciences; 1975
3. Paul DB: The History of Newborn Phenylketonuria Screening in the US, Baltimore: Johns Hopkins University Press; 1998
4. Dobson JC, Williamson ML, Azen C, et al: Intellectual assessment of 111 four-year-old children with phenylketonuria, Pediatrics 1977; 60:822
5. O'Flynn ME, Holtzman NA, Blaskovics M, et al: The diagnosis of phenylketonuria: A report from the collaborative study of children treated for phenylketonuria. Am J Dis Child 1980; 134:769
6. Lenke RR, Levy HL: Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies. N Engl J Med 1980;303:120
7. Save Babies Through Screening Foundation. A parent's guide to newborn screening. Available at: www.savebabies.org/library/ HandoutAParentsGuidetoNBS.pdf. Accessed March 6, 2007
8. Millington DS, Kodo N, Norwood DL, et al: Tandem mass spectrometry: A new method for acylcamitine profiling with potential for neonatal screening for inborn errors of metabolism. J Inherit Metab Dis 1990;13:321
9. American College of Medical Genetics/American Society of Human Genetics Test and Technology Transfer Committee Working Group. Tandem mass spectrometry in newborn screening. Genet Med 2000;2:267
10. Rinaldo P, Hahn S, Matern D: Clinical biochemical genetics in the twenty-first century. Acta Paediatr Suppl 2004;93:22; discussion 27
11. Tarini BA, Christakis DA, Welch HG: State newborn screening in the tandem mass spectrometry era: More tests, false positives. Pediatrics 2006;118:456
12. American College of Medical Genetics, Newborn screening: Toward a uniform screening panel and system. Rockville, Md., 2005
13. Newborn Screening Committee, National newborn screening report for 1995. Atlanta, 1999.
14. National Newborn Screening and Genetics Resource Center. National newborn screening status report-2007. Austin, Texas
15. Stoddard JJ, Farrell PM: State-to-state variations in newborn screening policies. Arch Pediatr Adolesc Med 1997; 151:561
16. Botkin JR, Clayton EW, Fost INC, et al: Newborn screening technology: proceed with caution. Pediatrics 2006; 117:1793
17. Leonard JV, Dezateux C: Screening for inherited metabolic disease in newborn infants using tandem mass spectrometry. BMJ 2002;324:4
18. Wilson JMG, Junger JJ: Principles and practice of screening for disease. Vol 34. Geneva: World Health Organization; 1968
19. Morrison AS: Screening in chronic disease, ed 2. New York: Oxford University Press; 1992.
20. Ledley FD, Levy HL, Shih VE, et al: Benign methylmalonic aciduria. N Engl J Med 1984;311:1015
21. Lam WK, Cleary MA, Wraith JE, et al: Histidinaemia: A benign metabolic disorder. Arch Dis Child 1996;74:343
22. Stadler SC, Polanetz R, Maier EM, et al: Newborn screening for 3-methylcrotonyl-CoA carboxylase deficiency: population heterogeneity of MCCA and MCCB mutations and impact on risk assessment. Hum Mutat 2006;27:748
23. van Maldegem BT, Duran M, Wanders RJ, et al: Clinical, biochemical, and genetic heterogeneity in short-chain acyl-coenzyme A dehydrogenase deficiency. JAMA 2006;296:943
24. Netley C, Hanley WB, Rudner HL: Phenylketonuria and its variants: Observations on intellectual functioning. Can Med Assoc J 1984;131:751
25. Levy HL, Sepe SJ, Walton DS, et al: Galactose-1-phosphate uridyl transferase deficiency due to Duarte/galactosemia combined variation: Clinical and biochemical studies. J Pediatr 1978;92:390
26. Kaye CI, Accurso F, La Franchi S, et al: Newborn screening fact sheets. Pediatrics 2006; 118:e934
27. Bergman AB, Stamm SJ: The morbidity of cardiac nondisease in schoolchildren. N Engl J Med 1967;276:1008
28. Jacobs MT, Frush DP, Donnelly LF: The right place at the wrong time: Historical perspective of the relation of the thymus gland and pediatric radiology. Radiology 1999;210:11
29. Refetoff S, Harrison J, Karanfilski BT, et al: Continuing occurrence of thyroid carcinoma after irradiation to the neck in infancy and childhood. N Engl J Med 1975;292:171
30. Hildreth NG, Shore RE, Dvoretsky PM: The risk of breast cancer after irradiation of the thymus in infancy. N Engl J Med 1989;321:1281
31. Gordis L: Epidemiology, ed 3. Philadelphia: Elsevier; 2004
32. American College of Medical Genetics, Newborn screening ACT sheets and confirmatory algorithms. Available at: www.acmg.net/resources/policies/ ACT/condition-analyte-links.htm. Accessed March 6, 2007
33. Thoene J, Sweetman L, Shafai T, et al: Tyrosinemia associated with perinatal infection with cytomegalovirus. J Pediatr 1978;92:108
34. Techakittiroj C, Cunningham A, Hooper PF, et al: High protein diet mimics hypertyrosinemia in newborn infants. J Pediatr 2005;146:281
35. Waisbren SE, Albers S, Amato S, et al: Effect of expanded newborn screening for biochemical genetic disorders on child outcomes and parental stress. JAMA 2003;290:2564
36. Howell RR: The high price of false positives. Mol Genet Metab 2006;87:180
37. Lacey JM, Minutti CZ, Magera MJ, et al: Improved specificity of newborn screening for congenital adrenal hyperplasia by second-tier steroid profiling using tandem mass spectrometry. Clin Chem 2004;50:621
38. Bailey DB Jr., Skinner D, Warren SF: Newborn screening for developmental disabilities: Reframing presumptive benefit. Am J Public Health 2005;95:1889
39. Grosse SD, Boyle CA, Kenneson A, et al: From public health emergency to public health service: The implications of evolving criteria for newborn screening panels. Pediatrics 2006;117:923
40. Gostin L: Public health law: Power, duly, restraint. Berkeley: University of California Press; 2000
41. New England Newborn Screening Program. Optional disorders. Available at: www.umassmed.edu/nbs/screenings/disorders/optional.aspx. Accessed March 6, 2007
42. Gennaccaro, M, Waisbren SE, Marsden D: The knowledge gap in expanded newborn screening: survey results from paediatricians in Massachusetts. J Inherit Metab Dis 2005;28:819
43. Kemper AR, Uren RL, Moseley KL, et al: Primary care physicians' attitudes regarding follow-up care for children with positive newborn screening results. Pediatrics 2006;118:1836
44. Mayo Medical Laboratories, Supplemental newborn screening. Available at: www.mayoreferenceservices.org/mml/mml-sns-intro.asp. Accessed March, 6, 2007
45. Pediatrix Screening, Newborn Screening. Available at: www.pediatrix.com/ body_screening.cfm?id=222&oTopID=94. Accessed March 6, 2007
46. University of Colorado, Biochemical Genetics Laboratory, Expanded Newborn Screening. Available at: www.uchsc.edu/newbornscreening/. Accessed March 6, 2007
47. Baylor Health Care System, Supplemental newborn screening. Available at: www.baylorhealth.com/medicalspecialties/metabolic/newbornscreening/ packet.htm. Accessed March 6, 2007
48. Green NS, Pass KA: Neonatal screening by DNA microarray: Spots and chips. Nat Rev Genet 2005;6:147
49. Alexander D, van Dyck PC: A vision of the future of newborn screening. Pediatrics 2006;117:S350
50. Gardner P, Oltmaa E, Messner A, et al: Simultaneous multigene mutation detection in patients with sensorineural hearing loss through a novel diagnostic microarray: a new approach for newborn screening follow-up. Pediatrics 2006;118:985
51. Rock MJ, Hoffman G, Laessig RH, et al: Newborn screening for cystic fibrosis in Wisconsin: Nine-year experience with routine trypsinogen/DNA testing. J Pediatr 2005; 147(3 Suppl):S73